The National Cancer Institute (NCI) stands as the federal government's principal agency for cancer research and training. Located within the National Institutes of Health, the NCI drives scientific discovery, shapes policy, and delivers data that saves lives across the United States and around the world.
Mandate and Strategic Vision
Congress established the NCI to lead the National Cancer Program, coordinating research and support activities to improve patient outcomes. The institute formulates research priorities, funds investigator-initiated grants, and oversees a network of designated cancer centers. Its strategic plan emphasizes precision medicine, reducing cancer disparities, and accelerating the translation of laboratory findings into safe, effective treatments for every patient.
Research Infrastructure and Funding
The NCI supports a vast ecosystem of scientists, clinicians, and institutions through specialized programs and cooperative agreements. Key mechanisms include:
Designated Cancer Centers that foster collaboration between academic and community settings.
Clinical trials networks such as NCI-CTEP, which streamline phase I, II, and III studies.
Data commons and biospecimen repositories that enable secondary analysis across studies.
Career development awards and training grants that cultivate the next generation of cancer researchers.
Data, Surveillance, and Public Communication
Accurate information underpins the NCI's public health mission. The institute maintains robust surveillance systems, including the Surveillance, Epidemiology, and End Results (SEER) program and the Annual Report to the Nation on the Status of Cancer. These resources provide detailed statistics on incidence, mortality, and survival, informing both clinicians and policymakers.
SEER and Cancer Statistics
SEER tracks cancer trends across diverse U.S. populations, offering data on stage at diagnosis, treatment patterns, and survival by race, age, and geography. Researchers and advocates rely on these metrics to identify gaps, measure progress, and allocate resources effectively.
Patient Information and Support
For individuals facing a cancer diagnosis, the NCI serves as a trusted source of evidence-based guidance. Through Cancer.gov, the institute offers detailed descriptions of cancer types, treatment options, and supportive care strategies. Tools such as the Physician Data Query (PDQ) provide up-to-date summaries on cancer prevention, screening, and management, designed for both professionals and patients.
Global Collaboration and Policy Leadership
The NCI engages with international partners to address cancers that disproportionately affect low- and middle-income countries. Initiatives in infectious disease-related malignancies, tobacco control, and capacity building demonstrate a commitment to health equity on a global scale. The institute also advises federal agencies, contributing expertise on regulatory pathways, reimbursement policies, and ethical considerations in oncology research.
Innovation and the Future Landscape
Emerging fields such as immunotherapy, liquid biopsies, and artificial intelligence continue to reshape cancer care. The NCI actively supports foundational and translational research to integrate these advances into standard practice. By fostering interdisciplinary consortia and leveraging real-world data, the institute aims to deliver timely, personalized, and accessible treatments for all patients.
